1620 Investment Advisors’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32K Sell
1,110
-328
-23% -$7.33K 0.02% 367
2026
Q1
$24.4K Buy
1,438
+40
+3% +$858 0.02% 380
2025
Q4
$35.9K Hold
1,398
0.02% 333
2025
Q3
$30.1K Hold
1,398
0.02% 345
2025
Q2
$30.8K Sell
1,398
-10
-0.7% -$219 0.02% 353
2025
Q1
$31.5K Hold
1,408
0.02% 343
2024
Q4
$24.3K Sell
1,408
-2,094
-60% -$32.5K 0.02% 370
2024
Q3
$58.7K Buy
3,502
+106
+3% +$2.54K 0.04% 283
2024
Q2
$97.2K Buy
+3,396
New +$102K 0.07% 221

Other funds holding PGNY

1620 Investment Advisors's PGNY Position: Q2 2026 in Review

1620 Investment Advisors reduced its Progyny (PGNY) stake by 23% in Q2 2026, selling an estimated $7.33K and leaving 1,110 shares worth $32K. The position accounts for 0.02% of the portfolio, ranked #367.

1620 Investment Advisors first reported a position in PGNY in Q2 2024 and has held it in 9 quarters since. The position peaked at $97.2K in Q2 2024. 51 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • 1620 Investment Advisors held 1,110 shares of Progyny worth $32K as of Q2 2026.
  • 1620 Investment Advisors sold 328 Progyny shares in Q2 2026, an estimated $7.33K.
  • Progyny made up 0.02% of 1620 Investment Advisors's portfolio in Q2 2026, its #367 holding.
  • 1620 Investment Advisors first reported a position in Progyny in Q2 2024 and has held it in 9 quarters since.
  • 1620 Investment Advisors's Progyny position peaked at $97.2K in Q2 2024.
  • 51 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.